kisspeptin-9 [4478]
kisspeptin-9
| SMILES | CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O |
| InChIKey | ANGOCTQQCKYVPZ-FTBSUAHMSA-N |
| Sequence | GTSLSPPPE |
| HELM | PEPTIDE1{G.T.S.L.S.P.P.P.E}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 14 |
| Hydrogen bond donors | 11 |
| Rotatable bonds | 22 |
| Log P | -5.297 |
| Molecular weight (Da) | 883.4 |
| Stereochemistry info | partial |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
kisspeptin-9
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0